New­Vale un­veils $167M fund to back phar­ma ser­vice providers and 'old ideas that are work­ing'

Growth eq­ui­ty firm New­Vale Cap­i­tal of­fi­cial­ly broke cov­er with its $167 mil­lion fund on Mon­day morn­ing to back third-par­ty ser­vice providers that sup­port the drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER